Using the EMT-6 model Zhang et al. [69] demonstrated that tumor-infiltrating B cells (TIL-B) develop increased expression of LAP/TGF-β, CD80, CD86, and PD-L1 in vivo compared to splenic B cells. Here, CD274 is linked to neoplasm.